Surrey Business News

Uni­ver­sal Phar­ma­care is Needed – Es­pe­cially in Light of COVID-19 Eco­nomic and Health Im­pacts

- Business · Health · Pharmaceutical Industry · Society · Canada News · Industries · Surrey

The Sur­rey Board of Trade con­tin­ues to ad­vo­cate for a sin­gle-payer uni­ver­sal phar­ma­care pro­gram since 2016. With ris­ing costs of med­i­ca­tions, many busi­nesses are see­ing their bot­tom line erode and some find they sim­ply can­not af­ford to pro­vide in­sur­ance plans for their em­ploy­ees.

Heavy bur­den on busi­ness Drug cov­er­age in Canada is pro­vided through an in­com­plete patch­work of pri­vate and public pro­grams that vary across prov­inces. This frag­mented sys­tem lim­its peo­ple’s ac­cess to medicines, di­min­ishes our drug pur­chas­ing power, du­pli­cates ad­min­is­tra­tive costs, and iso­lates phar­ma­ceu­ti­cal man­age­ment from the man­age­ment of med­i­cal and hos­pi­tal care.

It is need­lessly cost­ing Cana­dian busi­nesses bil­lions of dol­lars every year. Pre­scrip­tion drugs are the largest and fastest grow­ing com­po­nent of ex­tended health ben­e­fits in Canada. Busi­ness own­ers should not be re­spon­si­ble for man­ag­ing ac­cess to these life­sav­ing med­i­ca­tions. No com­pa­ra­ble coun­try with uni­ver­sal health care re­quires in­di­vid­ual em­ploy­ers to do so.

MORE IN­FOR­MA­TION: busi­nessin­sur­rey.com/ pol­icy/so­cial-pol­icy/

 ??  ??

Newspapers in English

Newspapers from Canada